Baqsimi
Payments companies reported to CMS as associated with Baqsimi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Baqsimi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Baqsimi
These are the largest totals companies reported as associated with Baqsimi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brenda Bradfield | Greenwood Village, CO | Nurse Practitioner | $375.00 |
| Melissa Vansickel | Lone Tree, CO | Medical | $341.05 |
| Mark Stesin | Robbinsdale, MN | Endocrinology, Diabetes & Metabolism | $336.33 |
| Nina Le | New York, NY | Internal Medicine | $286.86 |
| Michael Loughner | Denver, CO | Endocrinology, Diabetes & Metabolism | $282.26 |
| Sunil Nayak | Greenwood Village, CO | Pediatric Endocrinology | $267.06 |
| Allison Kemp | Parker, CO | Physician Assistant | $251.53 |
| Andrew Garza | Dallas, TX | Medical | $249.66 |
| Omar Manlapaz | Duncanville, TX | Endocrinology, Diabetes & Metabolism | $229.12 |
| Tamra Srianant | Englewood, CO | Physician Assistant | $225.73 |
Prescribed Baqsimi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.